Latest Breaking News On - Prnewswire immix biopharma inc - Page 1 : comparemela.com

ImmixBio Announces FDA Orphan Drug Designation for IMX-110 for the Treatment of Soft Tissue Sarcoma

ImmixBio Announces FDA Orphan Drug Designation for IMX-110 for the Treatment of Soft Tissue Sarcoma
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesGabriel morrisImmix biopharma incNormalization technologyPrnewswire immix biopharma incDrug administrationHtm technologyOffice of orphan products developmentTissue specific therapeuticsOrphan products developmentDrug designationIlya rachmanImmixbio founderImmixbio chief financial officerSystem multi action regulatorsImmix biopharma

ImmixBio Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate Combination of IMX-110 and Tislelizumab in Solid Tumors

ImmixBio Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate Combination of IMX-110 and Tislelizumab in Solid Tumors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesIlya rachmanGabriel morrisPrnewswire immix biopharma incBeigene ltdImmix biopharma incExchange commissionChina national medical products administrationNormalization technologyTissue specificTissue specific therapeuticsNorth americaSystem multi action regulatorsSecurities litigation reform act

ImmixBio Announces Dr George W Sledge of Stanford University Medical Center Joins Scientific Advisory Board

ImmixBio Announces Dr George W Sledge of Stanford University Medical Center Joins Scientific Advisory Board
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesIlya rachmanGabriel morrisIndiana university simon cancer centerOncology drug advisory committeeIndiana university cancer centerAmerican society of clinical oncologyOncology at stanford university medical centerPrnewswire immix biopharma incTulane universityAdvisory committeeHope funds for cancer researchUniversity of wisconsinImmix biopharma incPathology of indiana university school medicineTissue specific therapeutics

ImmixBio Announces Helen C Adams Joins Board of Directors

ImmixBio Announces Helen C Adams Joins Board of Directors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSan diego state universitySan marcosIlya rachmanHelenc adamsGabriel morrisPrnewswire immix biopharma incCompensation committeeTechnology groupAudit committeeImmix biopharma incCalifornia state university at san marcos foundationPrometheus biosciences incCompany board of directorsDeloitte touche

ImmixBio Announces Gabriel Morris as Chief Financial Officer and a Member of the Board of Directors

ImmixBio Announces Gabriel Morris as Chief Financial Officer and a Member of the Board of Directors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoIlya rachmanGabriel morrisPrnewswire immix biopharma incGoldman sachsColumbia universityImmix biopharma incGoldman sachs coTissue specific therapeuticsChief financial officerZap surgical systemsImmixbio chief executiveSystem multi action regulatorsஒன்றுபட்டது மாநிலங்களில்சான் பிரான்சிஸ்கோ